MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
MCHP HOLD REF $84 PW TARGET $84 (+0% vs spot · 12m PWEV) 0% Single-name research · 8 July 2026
Equity ResearchInformation Technology · Semiconductors
MCHP

Microchip Technology Inc (MCHP)

HOLD. 12-month probability-weighted target $84 (+0% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $77 (-9% vs spot · triangulated FV)
Reference
$84
Close · 8 July 2026
PW Target
$84 (+0% vs spot · 12m PWEV) 0%
Probability-weighted
Horizon
12 mo
MCH Advisory
$77 (-9% vs spot · triangulated FV)
Fair value
$84 (+0% vs spot · 12m PWEV)
Scenario PWEV
28.5x
Forward P/E
$48B
Market cap
$48–$105
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · quality defensive · conviction: medium

Metric Value
Current Price $84
Triangulated Fair Value $77 (-9% vs spot · triangulated FV)
12-mo Scenario PWEV $84 (+0% vs spot · 12m PWEV)
Forward P/E 28.5x
Market Cap $48B
52-Week Range $48–$105

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction quality defensive · medium
Triangulated fair value $77 (-9% vs spot · triangulated FV)
12-mo scenario PWEV $84 (+0% vs spot · 12m PWEV)
Next catalyst 2026-08-05 — Fiscal-Q1 print — key read on inventory-correction bottoming and book-to-bill crossing 1.0
Primary thesis-break Sequential revenue growth (quarter-on-quarter) < -0.05 (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies +0% vs spot
  • Monte Carlo median implies -6% vs spot
  • DCF fair value implies -18% vs spot — but this is terminal-value sensitive (exit-multiple $69 vs Gordon $38, 44% apart), so it carries less weight
  • Bear case (Structural — AI-Capex Digestion / China / Export Controls) downside is -54% vs spot
  • Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $91.20 on a ~31x forward multiple, the market prices Microchip for a clean mid-cycle recovery: revenue back to trend, operating margin restored to the high-30s, and AI/datacenter content offsetting the auto and industrial down-legs. The engine is more cautious. The probability-weighted target of $88.50 sits just below spot, and the DCF anchors at roughly $73 per share, well under the multiple-driven view — the gap is the tell that the current price already discounts most of the recovery. Monte Carlo variance is dominated by the P/E multiple (78% of dispersion), so the rating hangs on re-rating, not earnings. The Base scenario (35% weight) implies EPS near $2.95 and a $88 target; the structural down-case sits below the $47.57 52-week low by construction. That balance justifies a HOLD rather than a buy. The single most damaging risk: trailing free cash flow no longer covers the dividend, so a China-plus-inventory shock that stalls the recovery would strain the payout against $5.29B of net debt.

The dashboard below is the whole argument on one page: spot ($84) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $84 spot from $69 to $84 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The five valuation anchors bracket the $84 spot from $69 to $84 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The highest-probability bear case is the shared semi downturn — AI-capex digestion combined with China and export-control loss. The mechanism is concrete. Datacenter customers over-ordered into the AI build-out; as they digest inventory, Microchip's book-to-bill stays below parity and fab utilisation falls. Under-utilisation charges drag gross margin into the mid-50s, compressing operating margin well below the high-30s the Base case assumes. Simultaneously, export controls and Chinese localisation permanently displace a slice of demand rather than deferring it. Earnings and the multiple then compress together: EPS falls toward $1.86 and the multiple de-rates to the low-20s, driving the target below the 52-week low. With the dividend already exceeding trailing free cash flow, this is the scenario that forces a capital-allocation reckoning.

Key Debate

P/E Multiple explains 78% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.40 vs analyst floor +0.20 → delta +0.20 (n=41 mgmt / 24 Q&A; 13th pctile across the S&P book, z -1.2).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

Quarter Mgmt Analyst Delta
2026Q2 +0.40 +0.20 +0.20
2026Q1 +0.45 +0.35 +0.10
2025Q4 +0.49 +0.32 +0.17
2025Q3 +0.09 +0.00 +0.09

News (last 365d, 1000 articles): avg ticker sentiment +0.23 (bullish 34% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — AI-Capex Digestion / China / Export Controls' downside ($39) to a 'Bull — Supercycle Re-Rate' bull case ($148); the probability-weighted blend (PWEV $84) is +0% versus spot.

Scenario Probability Target Return vs spot
Structural — AI-Capex Digestion / China / Export Controls 20% $39 -54%
Cyclical Downturn — Inventory Correction 17% $62 -27%
Base — Mid-Cycle + AI Content 35% $88 +5%
Upcycle — AI / Datacenter Demand 20% $116 +38%
Bull — Supercycle Re-Rate 8% $148 +76%
Probability-Weighted (PWEV) $84 +0%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — AI-Capex Digestion / China / Export Controls (20%, $39). Structural impairment — AI-capex digestion / China / export controls: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 38.94; probability: 0.2.
  • Cyclical Downturn — Inventory Correction (17%, $62). Cyclical downturn — chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls weakens for 1–2 years before normalising. Drivers — implied_target: 66.13; probability: 0.17.
  • Base — Mid-Cycle + AI Content (35%, $88). Mid-cycle — normalised chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls; disciplined capital allocation; steady returns. Drivers — implied_target: 91.84; probability: 0.35.
  • Upcycle — AI / Datacenter Demand (20%, $116). Upside — AI + datacenter demand supercycle lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 123.99; probability: 0.2.
  • Bull — Supercycle Re-Rate (8%, $148). Upside tail — sustained tight conditions or a structural re-rate on AI + datacenter demand supercycle. Drivers — implied_target: 156.59; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $84 spot; PWEV $84 (+0% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $39–<img src=
Five-scenario tree. Probability-weighted targets around the $84 spot; PWEV $84 (+0% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $39–$148)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $79 -6%
Peer P/E re-rate multiple $82 -2%
Peer EV/Revenue re-rate multiple $131 +56%
Scenario PWEV multiple $84 +0%
DCF (5-year + terminal) cash flow + terminal × $69 -18%
Triangulated (weighted) $77 -9%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $79 and 45% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (78% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median $79; P(price > current) 45%. P10–P90: $44–<img src=
Monte Carlo distribution. Median $79; P(price > current) 45%. P10–P90: $44–$135.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 10.0%, 26x terminal FCF multiple → $69. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 10.0%, 26x terminal → $69.
Independent DCF. WACC 10.0%, 26x terminal → $69.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 27.84x) implies $82. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 27.84x → $82; EV/Rev re-rate → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 27.84x → $82; EV/Rev re-rate → $131.

Across all anchors the spread is 76% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Semiconductors $4.7B 100% 10% 38% $1.8B 30x 10% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls
net_debt_or_cash_b -5.29

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.1
div_yield 0.0195

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside AI-capex digestion / China / export controls
upside AI + datacenter demand supercycle

Industry Context — Information Technology — Semis

This name sits in the Information Technology — Semis as a semiconductors. chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: AVGO (semiconductors) · AMD (semiconductors) · INTC (semiconductors) · AMAT (semi_equipment) · KLAC (semi_equipment) · TXN (semiconductors) · MRVL (semiconductors) · QCOM (semiconductors) · ADI (semiconductors) · NXPI (semiconductors) · MPWR (semiconductors) · TER (semi_equipment) · MCHP (semiconductors) · ON (semiconductors) · Q (semi_equipment) · SWKS (semiconductors)

Shared state Capex path House view This name implies
Semi Downturn — AI-Capex Digestion / China 37% 37%
Mid-Cycle — Normalised + AI Content 35% 35%
Upcycle — AI / Datacenter Supercycle 28% 28%

Mapping note: name-level 'Structural — AI-Capex Digestion / China / Export Controls' (20%) + 'Cyclical Downturn — Inventory Correction' (17%) map to cluster Semi Downturn — AI-Capex Digestion / China (37%); name-level 'Upcycle — AI / Datacenter Demand' (20%) + 'Bull — Supercycle Re-Rate' (8%) map to cluster Upcycle — AI / Datacenter Supercycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Semi Downturn — AI-Capex Digestion / China () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The it_semis cycle is the shared macro driver. Driver — chip demand (AI/datacenter, auto, mobile) + semi cycle + WFE capex + China/export controls Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $5B $2B $0B $0B $2B $2B
FY+2 $6B $2B $0B $0B $2B $2B
FY+3 $6B $3B $0B $0B $2B $2B
FY+4 $6B $3B $0B $0B $2B $1B
FY+5 $7B $3B $0B $0B $2B $1B
Terminal $2B × 26x $37B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 10% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 10.0% · Σ PV(FCF) $8B + PV(terminal) $37B = EV $45B; + net cash → equity $39B ÷ diluted shares 0.57B = $69/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $38/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 49% vs WACC 10% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
NVDA 18.75x 22.68x 10% 66%
AVGO 24.69x 33.0x 10% 49%
MU 14.96x 10.54x 10% 68%
TXN 15.45x 39.84x 10% 38%
Median 17.1x 27.84x

Peer-median fwd P/E → $82; EV/Rev → $131.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $69 41% $28
Scenario PWEV $84 29% $25
Monte Carlo median $79 18% $14
Peer P/E $82 12% $10
Triangulated 100% $77

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 18.2x 22.1x 26.0x 29.9x 33.8x
8% $55 $65 $76 $86 $97
9% $52 $62 $72 $82 $92
10% $49 $59 $69 $78 $88
11% $47 $56 $66 $75 $84
12% $45 $54 $63 $71 $80

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $53 $56 $58 $61 $63
-1.5pp $58 $61 $63 $66 $69
+0.0pp $63 $66 $69 $72 $75
+1.5pp $68 $71 $74 $78 $81
+3.0pp $74 $77 $80 $84 $87

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Revenue CAGR ±3pp $58 $80 $22
Terminal × ±15% $59 $78 $19
Op margin ±3pp $63 $75 $12
WACC ±1pp $66 $72 $7
Capex intensity ±15% $67 $71 $4

Company lever — SoP/share vs Semiconductors multiple (AI re-rating) (base 30x)

Multiple 21.0x 25.5x 30.0x 34.5x 39.0x
SoP/share $164 $201 $238 $275 $312

Consensus & Market Expectations

Reference Value
Street target (mean) $113 (+34% vs spot · street)
House target $88 (-21.7% vs street)
Sell-side coverage 26 analysts (SB 3 / B 17 / H 5 / S 0 / SS 1; net score 0.4)
Consensus FY EPS $4.11; house below (-28.3%)
Consensus FY revenue $7.1B; house below (-27.0%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $5.3B — highly levered
Net debt / EBITDA 4.34x
Interest coverage (EBIT / interest) 3.2x
Current ratio 2.09x
Lease obligations $0.0B
Cash & ST investments $0.2B

Balance-sheet data as of 2026-03-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $0.9B
Buybacks / dividends $0.2B / $1.1B
Total shareholder yield 2.6%
Payout as % of FCF 146.4%
Reinvestment (capex / OCF) 9.5%
SBC as % of FCF 29.3%
Allocation stance returning more than FCF (balance-sheet funded)

Free-Cash-Flow Quality

Metric Value
FCF margin 18.5%
FCF conversion (FCF / net income) 378.7%
FCF yield 1.8%
Capex intensity (capex / revenue) 1.9%
FCF − SBC (diagnostic) $0.6B
Capex split (maint / growth) 40% / 60% — IDM fab model; capex ramps off a trough as utilisation recovers — the majority is growth/capacity (fab expansion, equipment) with the balance maintaining existing fabs

Accounting quality: SBC 5.4% of revenue; cash conversion (OCF/NI) 418% — cash-backed.

Catalyst Calendar

  • 2026-08-05 (~28d) — Fiscal-Q1 print — key read on inventory-correction bottoming and book-to-bill crossing 1.0 (authored)
  • 2026-08-06 (~29d) — Quarterly earnings — est. EPS $0.59 (AV EARNINGS_CALENDAR)
  • 2026-11-12 (~127d) — Capacity / fab-utilisation and Fab-2 / Fab-4 ramp update (authored)
  • 2027-03-31 (~266d) — Fiscal-year-end results + 9-point business-recovery-plan progress checkpoint (authored)

Forecast Track Record

  • EPS surprise: beat 75.0% of the last 8 quarters; average surprise +7.5%.

Competitive Moat

Narrow moat. Microchip's narrow moat comes from long-life 8/16/32-bit MCU + analog design-in stickiness and high customer/product count, not process leadership; that supports a mid-cycle terminal multiple around 18-20x but not the AI-supercycle multiple embedded in the bull case — the falsifiable test is book-to-bill and gross-margin recovery: if GM fails to recover above ~62% as the cycle turns, the design-in moat is weaker than claimed and the terminal multiple should compress toward ~15x.

Moat sources:

  • FACT: embedded MCU + analog design-ins carry long product lifecycles and high switching cost once designed into a board
  • FACT: >120,000 customers and a broad catalog reduce single-customer concentration
  • INFERENCE: the IDM (own-fab) model gives supply control but adds fixed-cost cyclicality vs fabless peers
  • ABSENCE: no process-node leadership and limited AI/datacenter content vs NVDA/AVGO — the AI narrative is adjacency, not core
Issue Probability Valuation sensitivity Horizon
US-China export controls / entity-list expansion restricting China-facing embedded/analog sales medium (~40%) medium - China is a material end-market ~5% of FV 12-24m
Tariffs / reshoring incentives (CHIPS-adjacent) altering fab economics and customer supply routing medium (~35%) low - IDM footprint is largely US ~2% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — AI-Capex Digestion / China / Export Controls AI-capex digestion drags broad-based semis, China demand is lost to export controls and local substitution, and the embedded cycle stays depressed permanent China share loss plus prolonged fab under-utilisation structurally impairs gross margin
Cyclical Downturn — Inventory Correction A 1-2 year inventory correction across auto/industrial/mobile embedded end-markets before restock under-utilisation charges persist longer than modeled, deepening the margin trough
Base — Mid-Cycle + AI Content Mid-cycle: inventory normalises, book-to-bill returns above 1.0, modest AI/datacenter content adds the recovery is shallower and later than assumed, delaying margin normalisation
Upcycle — AI / Datacenter Demand A broad semi upcycle with rising AI/datacenter connectivity and power content lifts volume and utilisation Microchip's AI content is thinner than peers', so it under-participates in the upcycle
Bull — Supercycle Re-Rate A multi-year supercycle plus a growth-multiple re-rate on peak-cycle earnings the re-rate capitalises cyclical-peak margins into a terminal multiple the narrow moat cannot sustain

What the Market Is Pricing In

At the current price, the market pays 20.5× forward EPS, vs the house DCF terminal 26.0×, and a peer median 27.84×. The house DCF sits 18% below spot, so the market is pricing in more than the house case — roughly 1.7pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Metric Consensus House Importance
Revenue 7.1 5.2 High
EPS 4.1 3.0 Medium
Target price 113.0 88.5 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
NVDA 22.68× 10% 66% direct 100%
AVGO 33.0× 10% 49% direct 100%
MU 10.54× 10% 68% broad 25%
TXN 39.84× 10% 38% segment 50%

Quality-weighted forward P/E: 28.4× (simple median 27.84×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (Gordon) (low-confidence cross-check (>50% below median)). Anchor median 79.2. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $48–$105, centre $71 (-16% vs spot); spot sits at the 63th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $77 (-9% vs spot · triangulated FV)
Downside to bear case (Structural — AI-Capex Digestion / China / Export Controls) $39 (-54% vs spot · bear scenario)
Reward/risk ratio 0.2×
Margin of safety (FV vs spot) -10%
P(price > spot) — Monte Carlo 45%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $148.

Assumption Register

Assumption Value Used in Source
WACC 10.0% DCF discount rate estimate (CAPM)
Terminal multiple 26× DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (22.0); Terminal × ±15% (19.0); Op margin ±3pp (12.0); WACC ±1pp (7.0); Capex intensity ±15% (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $4.7B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $5.2B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $4.1127 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.573B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $5.295B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 10.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 26× house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 10%, terminal multiple 26×, FY+5 revenue $7B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Sequential revenue growth (quarter-on-quarter) < -0.05 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Two consecutive quarters of sequential decline steeper than 5% would signal the inventory correction has deepened into a structural demand loss rather than a shallow cyclical dip, moving weight from Cyclical toward Structural.
  • Non-GAAP gross margin < 0.58 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Gross margin below 58% for two prints indicates sustained under-utilisation charges rather than a transient dip, undercutting the mid-cycle operating-margin recovery the Base path assumes.
  • Book-to-bill ratio < 0.9 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). A book-to-bill below parity for two quarters confirms orders are not replacing shipments, validating the inventory-correction mechanism and lengthening the down-leg.
  • China revenue share of total < 0.18 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). A sustained fall in China exposure below the high-teens would confirm export-control and localisation displacement is permanent rather than a timing effect, feeding the Structural scenario.
  • Trailing free cash flow less dividends paid < 0.0 (2 consecutive prints → Mid-Cycle — Normalised + AI Content). With ~$5.3B net debt and a ~1.95% dividend, two quarters where free cash flow fails to cover the dividend would pressure the payout and de-rate the shareholder-return case central to the Base thesis.

Fact / Inference / Speculation

  • FACT: Spot $84; 52-week range $48–$105; engine rating HOLD; base-case target $88 (+5%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $77 (-9% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: HOLD

Balanced: triangulated fair value $77 (-9% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.